LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.01 | 27.76 | 4186 | 7000 | 0.5980 | 0.8752 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.01 | 27.76 | 181 | 7000 | 0.0259 | 0.2649 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.01 | 27.76 | 5267 | 7000 | 0.7524 | 0.9299 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 83.72 | 27.76 | 89 | 7055 | 0.0126 | 0.1570 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 83.72 | 27.76 | 4217 | 7055 | 0.5977 | 0.8752 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 83.72 | 27.76 | 175 | 7055 | 0.0248 | 0.2592 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 83.72 | 27.76 | 5427 | 7055 | 0.7692 | 0.9354 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 85.42 | 27.76 | 91 | 7025 | 0.0130 | 0.1604 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 85.42 | 27.76 | 4348 | 7025 | 0.6189 | 0.8833 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 85.42 | 27.76 | 216 | 7025 | 0.0307 | 0.2930 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 85.42 | 27.76 | 5592 | 7025 | 0.7959 | 0.9436 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.13 | 27.76 | 79 | 6987 | 0.0113 | 0.1401 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.13 | 27.76 | 4375 | 6987 | 0.6261 | 0.8860 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.13 | 27.76 | 223 | 6987 | 0.0319 | 0.2986 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.13 | 27.76 | 5740 | 6987 | 0.8214 | 0.9513 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.84 | 27.76 | 54 | 6965 | 0.0078 | 0.0871 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.84 | 27.76 | 4426 | 6965 | 0.6355 | 0.8894 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.84 | 27.76 | 200 | 6965 | 0.0287 | 0.2811 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.84 | 27.76 | 5863 | 6965 | 0.8418 | 0.9573 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.55 | 27.76 | 64 | 6928 | 0.0092 | 0.1106 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.55 | 27.76 | 4472 | 6928 | 0.6454 | 0.8930 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.55 | 27.76 | 189 | 6928 | 0.0273 | 0.2724 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.55 | 27.76 | 5947 | 6928 | 0.8583 | 0.9620 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.25 | 27.76 | 72 | 6873 | 0.0105 | 0.1273 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.25 | 27.76 | 4623 | 6873 | 0.6726 | 0.9027 | MN20160318_Q01 | E22 |